Recommendations to Reduce the Risk of Transmission of Human Immunodeficiency Virus (HIV) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) ; Draft Guidance for Industry
FDA-2022-D-0467-0002Other
Document
Details
The document's own metadata, straight from the source system.
- Title
- Recommendations to Reduce the Risk of Transmission of Human Immunodeficiency Virus (HIV) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) ; Draft Guidance for Industry
- Posted
- Jan 7, 2025